Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300841 stock hub

SHE/300841 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300841is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300841

In the news

Latest news · SHE/300841

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.9

P25 17.1P50 24.2P75 37.8

Trailing P/E33.3

P25 23.5P50 41.3P75 83.2

ROE6.4

P25 -0.9P50 4.1P75 8.8

ROIC8.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300841 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	620
Employees Change	-52%
Employees Change Percent	-7.74
Enterprise value	CNY 6.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100003Y57
Last refreshed	2026-05-10
Market cap	CNY 7.5B
Price	CNY 58.08
Price currency	CNY
Rev Per Employee	2,180,927.13x
Sector	Healthcare
Sic	2836
Symbol	she/300841
Website	https://www.kangh.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3%
EV Earnings	28.79x
EV/EBIT	25.37x
EV/EBITDA	19.61x
EV/FCF	18.13x
EV/Sales	5.44x
FCF yield	4.77%
Forward P/E	27.92x
P/B ratio	2.12x
P/E ratio	33.31x
P/S ratio	6.29x
PE Ratio3 Y	26.22x
PE Ratio5 Y	25.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.43%
EBITDA Margin	27.73%
FCF margin	29.99%
Gross margin	90.93%
Gross Profit	CNY 1.1B
Gross Profit Growth	-7.43%
Gross Profit Growth Q	20.45%
Gross Profit Growth3 Y	-6.95%
Gross Profit Growth5 Y	0.78%
Net Income	CNY 226.6M
Net Income Growth	-16.06%
Net Income Growth Q	32.14%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-26.39%
Net Income Growth5 Y	-12.58%
Pretax Margin	22.44%
Profit Margin	18.89%
Profit Per Employee	CNY 411,914
Profitable Years	11
ROA	4.12
Roa5y	9.52
ROCE	7.14
ROE	6.44
Roe5y	17.95
ROIC	8.54
Roic5y	23.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.92%
Cagr3y	-10.37%
Cagr5y	-18.83%
Div CAGR3	-12.64%
EPS Growth	-15.52
EPS Growth Q	32.12
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-25.66
EPS Growth5 Y	-13.04
FCF Growth	10.1%
FCF Growth5 Y	17.89%
OCF Growth	-8.69%
OCF Growth3 Y	8.83%
OCF Growth5 Y	6.67%
Revenue Growth	-4.68x
Revenue Growth Q	25.02x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.3x
Revenue Growth5 Y	1.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.31
Assets	CNY 3.9B
Cash	CNY 1.1B
Current Assets	CNY 2.4B
Current Liabilities	CNY 308.5M
Debt	CNY 30.1M
Debt EBITDA	CNY 0.09
Debt Equity	CNY 0.01
Debt FCF	CNY 0.08
Equity	CNY 3.6B
Interest Coverage	88.19
Liabilities	CNY 341.5M
Long Term Assets	CNY 1.5B
Long Term Liabilities	CNY 32.9M
Net Cash	CNY 1B
Net Cash By Market Cap	CNY 13.58
Net Cash Growth	33.01%
Net Debt EBITDA	CNY -3.08
Net Debt Equity	CNY -0.29
Net Debt FCF	CNY -2.85
Tangible Book Value	CNY 3.6B
Tangible Book Value Per Share	CNY 27.32
WACC	7.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.89
Inventory Turnover	0.64
Net Working Capital	CNY 1.1B
Quick ratio	7.36
Working Capital	CNY 2.1B
Working Capital Turnover	CNY 0.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.64%
Dividend Growth	-50%
Dividend Growth Years	0%
Dividend per share	CNY 0.5
Dividend Years	5
Dividend Yield	0.86%
Ex Div Date	2025-05-20
Last Dividend	CNY 1
Payout Frequency	Annual
Payout Ratio	58.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.91%
200-day SMA	71.92
3Y total return	-27.99%
50-day SMA	59.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.75%
All Time High	442.7
All Time High Change	-86.88%
All Time High Date	2020-08-04
All Time Low	37.53
All Time Low Change	54.76%
All Time Low Date	2020-06-16
ATR	1.92
Beta	0.57
Beta1y	0.59
Beta2y	0.71
Ch YTD	-19.62
High	59.38
High52	94.3
High52 Date	2025-08-15
High52ch	-38.41%
Low	57.9
Low52	51.53
Low52 Date	2025-05-20
Low52ch	12.71%
Ma50ch	-2.89%
Price vs 200-day SMA	-19.25%
RSI	47.53
RSI Monthly	44.03
RSI Weekly	37.51
Sharpe ratio	0.11x
Sortino ratio	0.3
Total Return	1.5%
Tr YTD	-19.62
Tr1m	2.33%
Tr1w	0.75%
Tr3m	-16.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 257M
Operating Income Growth	-32.69
Operating Income Growth Q	55.22
Operating Income Growth3 Y	-23.55
Operating Income Growth5 Y	-12.51
Operating margin	21.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,742,264%
Net Borrowing	-131,234,000
Shares Insiders	11.89%
Shares Institutions	14.38%
Shares Out	129,946,899
Shares Qo Q	-0.02%
Shares Yo Y	-0.64%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 359.7M
Average Volume	1,990,943.9x
Bv Per Share	27.43
CAPEX	CNY -57.6M
Ch1m	2.33
Ch1w	0.75
Ch1y	10.76
Ch3m	-16.91
Ch3y	-31.91
Ch5y	-67.17
Ch6m	-27.97
Change	-1.53%
Change From Open	-1.51
Close	58.98
Days Gap	-0.02
Depreciation Amortization	75,579,426
Dollar Volume	118,171,136.2
Earnings Date	2026-04-21
EBIT	CNY 257M
EBITDA	CNY 332.6M
EPS	CNY 1.74
F Score	5
FCF	CNY 359.7M
FCF EV Yield	5.51x
FCF Per Share	CNY 2.77
Financing CF	-264,111,298
Fiscal Year End	December
Founded	2,004
Graham Number	32.80356
Graham Upside	-43.52
Income Tax	CNY 42.7M
Investing CF	-329,404,677
Is Primary Listing	1
Last Earnings Date	2026-04-21
Last Report Date	2026-03-31
Last Split Date	2022-05-25
Last Split Type	Forward
Lynch Fair Value	CNY 8.72
Lynch Upside	-84.99
Ma150	70.62
Ma150ch	-17.76%
Ma20	58.48
Ma20ch	-0.69%
Net CF	-176,281,499
Next Earnings Date	2026-08-21
Open	58.97
P FCF Ratio	20.98
P OCF Ratio	18.09
Payment Date	2025-05-20
Position In Range	12.16
Ppne	858,317,749
Price Date	2026-05-08
Price EBITDA	CNY 22.69
Ptbv Ratio	2.13
Relative Volume	1.04x
Revenue	1,199,509,922x
Tax By Revenue	3.56x
Tax Rate	15.85%
Tr6m	-27.97%
Volume	2,034,627
Z Score	17.97

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300841 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$0.50 annual per share

Payout ratio

+58.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2025-05-20

Performance

SHE/300841 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300841?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.4%

Share of float held by funds and institutions

Insider ownership

+11.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

SHE/300841 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.5

Neutral momentum band

Price vs 200-day MA

-19.2%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300841

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300841 stock rating?

she/300841 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300841 analysis?

The full report lives at /stocks/she/300841/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300841?

The latest report frames she/300841 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300841 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.